WATSON 415 (Estropipate 1.5 mg)
Pill imprint WATSON 415 has been identified as Estropipate 1.5 mg.
Estropipate is used in the treatment of atrophic urethritis; atrophic vaginitis; osteoporosis; postmenopausal symptoms; primary ovarian failure (and more), and belongs to the drug class estrogens. Not for use in pregnancy. Estropipate 1.5 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
More about estropipate
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.